Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 9 de 9
Filtrar
Mais filtros

Base de dados
Tipo de documento
Intervalo de ano de publicação
2.
Artigo em Inglês | MEDLINE | ID: mdl-39154954

RESUMO

STUDY OBJECTIVE: As part of a larger study about pregnancy options counseling with adolescents, we interviewed women in the United States who chose abortion during adolescence about preferences and experiences regarding communication from healthcare professionals during abortion care. DESIGN, SETTING, AND PARTICIPANTS: We conducted individual semi-structured interviews with women ages 18-35 years old who were pregnant before age 20 years old and chose abortion. We recruited participants through social media, a research registry, and flyers in healthcare facilities. We recorded and transcribed interviews. Two investigators coded interview transcripts using thematic analysis. RESULTS: We conducted interviews with 17 US women (median age 32 years old, range 20-35 years old) from 11/2020-4/2021. The median age at time of abortion was 18 years old (range 14-19 years). The sample was 58% (n = 10) Caucasian and 65% (n = 11) heterosexual. Themes included: 1) Participants perceived options counseling before abortion as important and necessary but did not always feel they personally needed it. 2) Participants reported that clinicians including nurses, physicians, and other staff sometimes had poor bedside manner, which was not aligned with their perceived need for gentleness due to their adolescence. 3) Participants valued nonjudgmental communication including normalization of abortion care. 4) Participants desired privacy and confidentiality throughout their clinic appointment, but clinic logistics led to concerns about limited privacy. 5) Participants appreciated medically accurate information about abortion in plain language balancing safety and risk information for reducing fear before the procedure. CONCLUSION: Responses suggested specific best practices that healthcare providers can adopt to improve care for youth considering abortion.

3.
J Adolesc Health ; 74(2): 320-326, 2024 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-37815763

RESUMO

PURPOSE: Clinical trial data support use of medications for opioid use disorder (MOUD) in adolescents and young adults ("youth"), but qualitative data are lacking on the acceptability and importance of MOUD to youth, caregivers, and clinicians. We assessed how these stakeholders viewed the role of MOUD in treatment and recovery. METHODS: We recruited youth aged from 15 to 25 years with opioid use disorder who had received buprenorphine, naltrexone, or methadone and caregivers from a primary care-based youth addiction treatment program. We also recruited clinicians with addiction expertise from social work, nursing, pediatrics, internal medicine, and psychiatry. We conducted semistructured interviews assessing special considerations for MOUD use in youth. Three coders performed inductive and deductive thematic analysis of transcripts. RESULTS: Among 37 participants, including 15 youth (age range, 17-25 years), nine caregivers, and 13 clinicians, we identified three themes. (1) Medications support recovery in the short term: Youth described MOUD as beneficial in managing withdrawal symptoms. Notably, some youth and caregivers preferred to limit MOUD duration. (2) Medication adherence is affected by type of medication, dosing regimen, and route of administration. Participants endorsed long-acting, injectable MOUD for ease of use and youth's ability to continue engagement in "normal activities" without daily medication. (3) Caregiver involvement can support medication decisions and adherence. Youth and some clinicians described the need to assess caregiver involvement before incorporating them into treatment; caregivers and other clinicians described caregivers as critical in supporting accountability. DISCUSSION: MOUD is evidence-based, and its provision should be developmentally responsive and youth- and family-centered, incorporating caregivers when appropriate.


Assuntos
Buprenorfina , Transtornos Relacionados ao Uso de Opioides , Adulto Jovem , Humanos , Adolescente , Criança , Adulto , Cuidadores , Transtornos Relacionados ao Uso de Opioides/tratamento farmacológico , Transtornos Relacionados ao Uso de Opioides/diagnóstico , Buprenorfina/uso terapêutico , Naltrexona/uso terapêutico , Metadona , Analgésicos Opioides/uso terapêutico
4.
Pharmacogenomics ; 24(17): 881-893, 2023 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-37975236

RESUMO

Aim: To advance clinical adoption and implementation of pharmacogenomics (PGx) testing, barriers and facilitators to these efforts must be understood. This study identified and examined barriers and facilitators to active implementation of a PGx program across multiple clinic settings in an academic healthcare system. Materials & methods: 28 contributors to the PGx implementation (e.g., clinical providers, informatics specialists) completed an interview to elicit their perceptions of the implementation. Results: Qualitative analysis identified several barriers and facilitators that spanned different stages of the implementation process. Specifically, unclear test payment mechanisms, decision support tool development, rigid workflows and provider education were noted as barriers to the PGx implementation. A multidisciplinary implementation team and leadership support emerged as key facilitators. Furthermore, participants also suggested strategies to overcome or maintain these factors. Conclusion: Assessing real-world implementation perceptions and suggested strategies from a range of implementation contributors facilitates a more comprehensive framework and best-practice guidelines for PGx implementation.


Assuntos
Atenção à Saúde , Farmacogenética , Humanos
5.
J Adolesc Health ; 73(1): 164-171, 2023 07.
Artigo em Inglês | MEDLINE | ID: mdl-37032209

RESUMO

PURPOSE: Perspectives of adolescents and young adults (AYAs) experiencing pregnancy options counseling (POC) are absent from the literature. This study explores AYA experiences and preferences related to POC to inform best practice guidelines. METHODS: We conducted semistructured phone interviews in 2020-2021 among US-based individuals, 18-35 years old, who experienced a pregnancy less than 20 years of age. We performed qualitative descriptive analysis of positive and negative attributes of AYA's experiences with POC. RESULTS: Fifty participants reported 59 pregnancies (16 parenting, 19 abortions, 18 adoptions, three miscarriages) between the ages of 13 and 19 years. Positive attributes of POC experienced included: (1) provider communication that was compassionate, respectful, supportive, and attentive to nonverbal cues; (2) provider neutrality; (3) discussion of all pregnancy options; (4) asking about feelings, choice, life plans, and additional supports; (5) provision of informational materials; and (6) warm handoffs/follow-up facilitation. Negative attributes of POC experienced included: (1) judgmental, impersonal, or absent communication; (2) lack of counseling on all options and/or coercive/directive counseling; (3) insufficient time and supportive resources; and (4) confidentiality concerns. We identified no differences in these perspectives across pregnancy outcomes reported. Participants generally desired counseling about all options, with rare exceptions of ambivalence. DISCUSSION: Individuals who experienced an adolescent pregnancy described similar positive and negative attributes of POC regardless of preferred pregnancy outcome. Their perspectives highlight how crucial interpersonal communication skills are for effective POC for AYA. POC training across health care specialties should emphasize confidential, compassionate, and nonjudgmental care for AYA patients.


Assuntos
Aborto Induzido , Aborto Espontâneo , Gravidez na Adolescência , Feminino , Adulto Jovem , Gravidez , Humanos , Adolescente , Adulto , Aconselhamento , Aborto Induzido/psicologia , Pesquisa Qualitativa
6.
Curr Opin Pediatr ; 35(4): 408-414, 2023 08 01.
Artigo em Inglês | MEDLINE | ID: mdl-36974444

RESUMO

PURPOSE OF REVIEW: Adolescent and young adult overdoses and overdose fatalities continue to increase despite reductions in self-reported substance use. This review aims to explore factors contributing to this overdose epidemic, highlight signs of overdose and the role of the overdose reversal medication naloxone, and provide recommendations for practice change to support patients and decrease their risk of unintentional overdose. RECENT FINDINGS: The potent opioid fentanyl is a common contaminant in nonopioid substances, as well as in heroin and counterfeit pills, heightening risk of fatal overdose. Adolescents and young adults who die of overdose are rarely engaged in substance use disorder treatment. Medications for opioid use disorder are effective at reducing risk of fatal overdose but are underutilized, as is the opioid reversal medication naloxone. SUMMARY: Pediatric clinician engagement in harm reduction with adolescents and young adults, starting with screening through a confidential interview, may enhance pathways to care and reduce the risk of overdose.


Assuntos
Overdose de Drogas , Transtornos Relacionados ao Uso de Opioides , Adulto Jovem , Adolescente , Humanos , Criança , Fentanila/efeitos adversos , Analgésicos Opioides/efeitos adversos , Redução do Dano , Overdose de Drogas/prevenção & controle , Overdose de Drogas/tratamento farmacológico , Overdose de Drogas/epidemiologia , Naloxona/uso terapêutico , Transtornos Relacionados ao Uso de Opioides/epidemiologia , Transtornos Relacionados ao Uso de Opioides/prevenção & controle
7.
Clin Pediatr (Phila) ; 61(12): 869-878, 2022 12.
Artigo em Inglês | MEDLINE | ID: mdl-35774009

RESUMO

As adolescent vaping reaches epidemic rates in the United States, it is imperative that pediatric clinicians have access to medical knowledge on best practices for screening, assessing, and treating vaping-related substance use. The Teen Vaping ECHO (Extension for Community Healthcare Outcomes) program was developed to offer practical learning sessions focused on clinical management of adolescent vaping. This study describes the development, implementation, and evaluation of the program's impact on participants' knowledge, attitudes, and practices regarding treatment of adolescent vaping from registration to the end of the series. Participants were generally knowledgeable about vaping at registration and reported significant increases in comfort talking with patients about vaping, counseling patients on nicotine replacement products, and frequency of implementing best-practice screening strategies at the end of the series. This study suggests ECHO programs focused on improving clinical management of adolescent vaping may increase accessibility of evidence-based care and reduce harms associated with vaping in youth.


Assuntos
Sistemas Eletrônicos de Liberação de Nicotina , Abandono do Hábito de Fumar , Vaping , Adolescente , Humanos , Estados Unidos , Criança , Vaping/efeitos adversos , Dispositivos para o Abandono do Uso de Tabaco , Serviços de Saúde Comunitária , Aconselhamento
8.
Acad Pediatr ; 22(6): 1017-1023, 2022 08.
Artigo em Inglês | MEDLINE | ID: mdl-34929388

RESUMO

INTRODUCTION: Individual-, school-, and neighborhood-level support and connectedness may help to mitigate against school suspensions, which have profound health and social consequences. Most research on social connectedness and suspension has focused only on school connectedness, and much less is known about the effects of individual social support and neighborhood-level connectedness on suspension. METHODS: We examined associations between all three levels of connectedness and suspension in a cross-sectional analysis of a population-based youth sample in Allegheny County, Pennsylvania. The Healthy Allegheny Teen Survey, a county-wide survey of 1813 male and female youth ages 14 to 19, assessed health risk/protective behaviors through random-digit-dialing in 2014. This survey included validated items evaluating each type of support as well as items assessing lifetime history of suspension. Logistic regression models examined associations between suspension and social support, school connectedness, and neighborhood-level cohesion. RESULTS: In fully adjusted logistic regression models examining associations between suspension and each type of support, youth with high social support had 0.38 times the odds of school suspension compared to youth with low social support (95% confidence interval [CI] 0.19-0.74). High levels of school connectedness and neighborhood-level cohesion were also associated with significantly lower odds of suspension (odds ratio [OR] 0.31, 95% CI 0.18-0.53; OR 0.28, 95% CI 0.16-0.47, respectively). Examining all 3 types of support jointly, school connectedness and neighborhood-level cohesion were significantly inversely related to suspension (OR 0.41, 95% CI 0.24-0.71; OR 0.41, 95% CI 0.23-0.74, respectively). CONCLUSIONS: Programs that foster connectedness at the individual-, school-, and neighborhood-level may help reduce school suspension.


Assuntos
Instituições Acadêmicas , Estudantes , Adolescente , Estudos Transversais , Feminino , Humanos , Masculino , Apoio Social , Suspensões , Adulto Jovem
9.
Subst Abus ; 43(1): 336-343, 2022.
Artigo em Inglês | MEDLINE | ID: mdl-34283701

RESUMO

Background: People with opioid use disorders (OUDs) are at heightened risk for involvement with the criminal justice system. Growing evidence supports the safety and effectiveness of providing empirically supported treatments for OUD, such as medications for OUD (M-OUD), to people with criminal justice involvement including during incarceration or upon reentry into the community. However, several barriers limit availability and accessibility of these treatment options for people with OUDs, including a shortage of healthcare and justice professionals trained in how to implement them. This study evaluated a novel education program, the Indiana Jail OUD Treatment ECHO, designed to disseminate specialty knowledge and improve attitudes about providing M-OUD in justice settings. Methods: Through didactic presentations and case-based learning (10 bimonthly, 90-min sessions), a multidisciplinary panel of specialists interacted with a diverse group of community-based participants from healthcare, criminal justice, law enforcement, and related fields. Participants completed standardized surveys about OUD knowledge and attitudes about delivering M-OUD in correctional settings. Thematic analysis of case presentations was conducted. Results: Among 43 participants with pre- and post-series evaluation data, knowledge about OUD increased and treatment was viewed as more practical after the ECHO series compared to before. Cases presented during the program typically involved complicated medical and psychiatric comorbidities, and recommendations addressed several themes including harm reduction, post-release supports, and integration of M-OUD and non-pharmacological interventions. Conclusions: Evaluation of future iterations of this innovative program should address attendance and provider behavior change as well as patient and community outcomes associated with ECHO participation.


Assuntos
Transtornos Relacionados ao Uso de Opioides , Adulto , Direito Penal , Atenção à Saúde , Medicina Baseada em Evidências , Humanos , Tratamento de Substituição de Opiáceos , Transtornos Relacionados ao Uso de Opioides/tratamento farmacológico
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA